Fuente: Labiotech Lugar: In Depth If 2025 was a consolidation year for radioligand therapies, 2026 might be about execution; delve into radiopharma 2026.
The post Will radioligand therapies keep the momentum going in 2026?  appeared first on Labiotech.eu.
© Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.